Breaking News Instant updates and real-time market news.

JBL

Jabil

$27.43

-2.65 (-8.81%)

, CLS

Celestica

$10.72

-0.14 (-1.29%)

13:35
09/25/18
09/25
13:35
09/25/18
13:35

Jabil falls after CEO commentary on margin and expansion, peers also fall

Shares of companies involved in electronics contract manufacturing services are faltering after peer Jabil (JBL) reported fourth quarter results on Monday evening. JABIL BEATS, BUT STOCK FALLS: Contract manufacturer Jabil reported Q4 results that beat expectations on both the top and bottom lines, due to the strong performance of its core businesses. Q4 earnings per share came in at 70c, beating the expected 68c and the year-ago result of 64c. Jabil reported Q4 revenue of $5.77B, up from $5.02B in Q4 of 2017. The company projected first quarter revenue in the range of $5.8B-$6.4B, compared with consensus estimates of $5.9B. NO MARGIN IMPROVEMENT SEEN FOR A WHILE: "We assume that from FY19 to FY21, we'll get no expansion, no leverage of margin," CEO Mark Mondello said on the company's Q4 earnings conference call. PRICE ACTION: In afternoon trading, shares of Jabil are down almost 9% to $27.38. PEERS: Shares of other electronic contract manufacturers are also down, including Celestica (CLS), Sanmina (SANM), Flex(FLEX), and Xilinx (XLNX).

JBL

Jabil

$27.43

-2.65 (-8.81%)

CLS

Celestica

$10.72

-0.14 (-1.29%)

SANM

Sanmina

$28.40

-0.9 (-3.07%)

FLEX

Flex

$12.97

-0.33 (-2.48%)

XLNX

Xilinx

$77.89

-1.26 (-1.59%)

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 01

    Oct

  • 09

    Oct

  • 13

    Nov

JBL Jabil
$27.43

-2.65 (-8.81%)

09/20/18
JPMS
09/20/18
NO CHANGE
Target $39
JPMS
Overweight
JPMorgan likes setup for Jabil shares into Q4 results
JPMorgan analyst Paul Coster believes the setup for shares of Jabil (JBL) "looks good" into the company's fiscal Q4 results on September 25. The analyst expects Jabil to post "solid results and issue "constructive" fiscal Q1 guidance given a backdrop of strong IT spending, ramping volumes at NCR (NCR), a new product cycle at GoPro (GPRO) and potentially higher year-over-year margins relating to the seasonal Apple (AAPL) business. The stock will "re-rate" exiting the Q2 print and heading into the new fiscal year, Coster tells investors in a pre-earnings research note. He keeps an Overweight rating on Jabil shares with a $39 price target.
03/20/18
UBSW
03/20/18
NO CHANGE
Target $35
UBSW
Buy
Jabil Circuit shares attractive at current levels, says UBS
UBS analyst Steven Milunovich recommends shares of Jabil Circuit (Jabil) and Flex (FLEX) on the belief that Electric Components & Equipment names are re-rating as they move up the value stack to design as well as manufacture products. Investor confidence has been greater in Flex than Jabil, in large part due to Jabil's 25% Apple (AAPL) exposure, Milunovich tells investors in a research note. After meeting with management, the analyst finds Jabil shares attractive based on $3.00 in earnings per share in fiscal 2019 and higher free cash flow. He maintains a Buy rating on Jabil with a $35 price target.
06/15/18
UBSW
06/15/18
NO CHANGE
Target $35
UBSW
Buy
Jabil Circuit shares look attractively valued, says UBS
UBS analyst Steven Milunovich noted Jabil Circuit (JBL) reported surprisingly strong revenue growth, but only modest earnings upside due to cost overruns. He said growth is reducing free cash flow this year but an increased buyback was announced and Apple (AAPL) has not been the albatross as had been feared because of the company's diversification. Milunovich said Jabil Circuit is attractive at its current valuation and he reiterated his Buy rating and $35 price target on the shares.
06/19/18
VERF
06/19/18
NO CHANGE
Target $29
VERF
Sell
SolarEdge included in second round of Trump's tariffs, says Vertical Group
Vertical Group analyst Gordon Johnson believes President Trump's second set of proposed tariffs on China include SolarEdge Technologies' (SEDG) power optimizers. This is bad for SolarEdge and not fully understood at present, Johnson tells investors in an emailed research note. The analyst thinks this introduces a "much more/immediate draconian risk" that could materially impact SolarEdge's sale of inverters into the U.S. market. A number of investors currently in the stock are not aware that SolarEdge outsources the production of its inverters/optimizers to Jabil Circuit (JBL), which are made mostly in China, Johnson contends. He keeps a Sell rating on SolarEdge shares with a $29 price target. The stock in midday trading is up 2% to $48.75.
CLS Celestica
$10.72

-0.14 (-1.29%)

SANM Sanmina
$28.40

-0.9 (-3.07%)

04/24/18
NEED
04/24/18
NO CHANGE
Target $40
NEED
Buy
Sanmina price target raised to $40 from $33 at Needham
Needham analyst Sean Hannan raised his price target on Sanmina to $40 and kept his Buy rating after the company's earnings beat, saying the "noise" impacting results in late 2017-early 2018 is being replaced by the "new, high-value wins". Hannan is especially positive on the company's ramp of activity in Auto, Medical and Optical segments.
04/13/18
SBSH
04/13/18
UPGRADE
SBSH
Buy
Citi upgrades Sanmina to Buy on conservative sales estimates
Citi analyst Jim Suva upgraded Sanmina to Buy from Neutral with a price target of $32. The analyst believes consensus sales estimates are too conservative and that fundamental softness in recent quarters is already priced in. Suva also upgraded the Electronics Manufacturing Services sector citing strong demand.
04/13/18
SBSH
04/13/18
UPGRADE
SBSH
Buy
Sanmina upgraded to Buy from Neutral at Citi
01/23/18
NEED
01/23/18
NO CHANGE
Target $33
NEED
Buy
Sanmina price target lowered to $33 from $45 at Needham
Needham analyst Sean Hannan lowered his price target on Sanmina to $33, saying the company's "ugly" Q1 preliminary result is the continuation of prior challenges. Hannan also cites a "slowness in new ramps, some cancellations, and tighter materials supply". The analyst notes that he still expects the aggregate ramp schedule to remain strong in the second half of 2018 and calls most issues "transitory", keeping his Buy rating on Sanmina.
FLEX Flex
$12.97

-0.33 (-2.48%)

05/11/18
UBSW
05/11/18
NO CHANGE
Target $18
UBSW
Buy
Flex near-term may be pressured but long-term better, says UBS
UBS analyst Steven Milunovich said Flex boosted its capital expenditure guidance, which may pressure the shares in the near-term as the company ramps up its investment. The analyst noted bookings were strong across the board and guidance was unchanged, giving him confidence in the longer-term outlook for the shares. Milunovich reiterated his Buy rating and $18 price target on Flex shares.
04/27/18
04/27/18
DOWNGRADE

Market Perform
Flex downgraded to Market Perform, growth pushed out at Raymond James
As previously reported, Raymond James downgraded Flex two notches to Market Perform from Strong Buy following Q4 results. Analyst Adam Tindle said the outsized profit growth he expected in FY19 appears to be back half weighted, at best. Tindle would wait for better visibility into CEC growth, profitability with Nike, and improved utilization in broader CTG before becoming constructive on shares.
04/27/18
SBSH
04/27/18
NO CHANGE
Target $16
SBSH
Buy
Flex earnings selloff brings buying opportunity, says Citi
Flex's (FLEX) March quarter results were filled with several items that will be viewed by investors as bad news, including a delay in profitability ramp from Nike (NKE) and an unrelated accounting investigation resulting in the stock trading down 15% after hours, Citi analyst Jim Suva tells investors in a research note. The analyst believes the stock pressure is warranted following the 25% gain last year, but does not think these items are a "structural flaw to the company's operations or cash flows." As such, Suva views today's stock pullback as a buying opportunity. The Nike issue should be fully resolved within six months and the accounting investigation appears limited, he argues. The analyst lowered his price target for Flex to $16 from $20 and keeps a Buy rating on the name.
06/18/18
STPT
06/18/18
UPGRADE
STPT
Buy
Flex upgraded to Buy from Hold at Standpoint Research
XLNX Xilinx
$77.89

-1.26 (-1.59%)

08/28/18
BARD
08/28/18
UPGRADE
BARD
Outperform
Xilinx upgraded to Outperform from Neutral at Baird
08/28/18
BARD
08/28/18
UPGRADE
Target $90
BARD
Outperform
Xilinx upgraded to Outperform on 5G-related order acceleration at Baird
As reported previously, Baird analyst Tristan Gerra upgraded Xilinx to Outperform from Neutral. The analyst said his field research suggests a very recent and significant acceleration in 5G-related orders for FPGAs scheduled for later this year. He also said data centers represent a longer-term significant growth avenue for the company. Gerra raised his price target to $90 from $71 on Xilinx shares.
08/28/18
08/28/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. APPLIED MATERIALS, LAM RESEARCH CUT TO NEUTRAL: BofA Merrill Lynch analyst Vivek Arya downgraded both Lam Research (LRCX) and Applied Materials (AMAT) to Neutral from Buy after lowering his wafer fab equipment growth outlook for this year to up 7% from up 10%. Arya also cut his estimates for 2019 and 2020, primarily to account for lower memory capital expenditures. He now expects relative growth in foundry/logic paired with declines in memory within the context of a "muted" WFE recovery in 2019. He lowered his price target on Applied shares to $49 from $65 and cut his target on Lam shares to $200 from $235. In late morning trading, Lam Research is down 2.5%, while Applied Materials is down 1%. BAIRD UPGRADES XILINX TO OUTPERFORM: Baird analyst Tristan Gerra upgraded Xilinx (XLNX) to Outperform from Neutral. The analyst said his field research suggests a very recent and significant acceleration in 5G-related orders for FPGAs scheduled for later this year. He also said data centers represent a longer-term significant growth avenue for the company. Gerra raised his price target to $90 from $71 on Xilinx shares. Xilinx is more than 2% higher in late morning trading. MORGAN STANLEY UPS COTY TO OVERWEIGHT: Morgan Stanley analyst Dara Mohsenian upgraded Coty (COTY) to Overweight from Equal Weight, pointing out that this is the first time the firm has had an Overweight rating on the stock since the company's 2013 IPO. Following four sell-side downgrades in the last two weeks and the stock's 40% year-to-date decline, Mohsenian now sees the risk/reward as "compelling," he told investors. Mohsenian, however, trimmed his price target on Coty shares to $14.50 from $17.00. Shares of Coty are up 6.6% in late morning trading. MORGAN STANLEY DISCUSSES MICROSOFT DIVIDEND RAISE: Morgan Stanley analyst Keith Weiss noted that Microsoft (MSFT) typically announces a dividend raise in mid-September and pointed out that the company has raised its dividend by an average of 14% annually since the financial crises in 2009, when the dividend was unchanged. He sees a higher probability of an above average dividend raise in September, noting that an increase of over 20% constitutes a raise larger than "normal" and would allow the dividend yield to return to above 2% despite strong stock performance over the last year. Weiss maintained his Overweight rating and $130 price target on Microsoft shares.
09/07/18
COWN
09/07/18
INITIATION
Target $81
COWN
Market Perform
Xilinx initiated with a Market Perform at Cowen
Cowen analyst Matthew Ramsay initiated Xilinx with a Market Perform rating as he believes the risk/reward is balanced at current levels given the stock's premium valuation. He told investors he was waiting for more tangible signs of traction against a compelling datacenter opportunity before recommending the shares. Ramsay has a $81 price target on Xilinx shares.

TODAY'S FREE FLY STORIES

JCP

J.C. Penney

$0.93

0.022 (2.42%)

, DDS

Dillard's

$56.57

0.25 (0.44%)

13:29
05/25/19
05/25
13:29
05/25/19
13:29
Periodicals
Target stock triumphs in brutal week for retail, Barron's says »

Earnings season has been…

JCP

J.C. Penney

$0.93

0.022 (2.42%)

DDS

Dillard's

$56.57

0.25 (0.44%)

KSS

Kohl's

$51.11

-0.04 (-0.08%)

JWN

Nordstrom

$33.50

-0.31 (-0.92%)

M

Macy's

$21.00

-0.27 (-1.27%)

TGT

Target

$81.57

2.17 (2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

JPM

JPMorgan

$109.78

1.14 (1.05%)

, AKZOY

AkzoNobel

$0.00

(0.00%)

13:24
05/25/19
05/25
13:24
05/25/19
13:24
Periodicals
Microsoft, JPMorgan among dividend champions, Barron's says »

Among the companies that…

JPM

JPMorgan

$109.78

1.14 (1.05%)

AKZOY

AkzoNobel

$0.00

(0.00%)

XOM

Exxon Mobil

$74.12

0.33 (0.45%)

MSFT

Microsoft

$126.23

0.04 (0.03%)

CMWAY

Commonwealth Bank of Australia

$0.00

(0.00%)

SIEGY

Siemens

$0.00

(0.00%)

T

AT&T

$32.29

0.15 (0.47%)

RDS.A

Royal Dutch Shell

$63.29

0.84 (1.35%)

RHHBY

Roche

$0.00

(0.00%)

NVS

Novartis

$87.49

3.03 (3.59%)

BHP

BHP Group

$52.47

1.18 (2.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 29

    May

  • 29

    May

  • 31

    May

  • 03

    Jun

  • 03

    Jun

  • 03

    Jun

  • 05

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 11

    Jun

  • 12

    Jun

  • 20

    Jun

  • 23

    Jun

  • 16

    Jul

  • 24

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 02

    Sep

  • 04

    Nov

GM

General Motors

$35.13

0.01 (0.03%)

, TSLA

Tesla

$190.80

-4.7 (-2.40%)

13:19
05/25/19
05/25
13:19
05/25/19
13:19
Periodicals
Tesla stock in trouble, Barron's says »

Tesla (TSLA) stock is the…

GM

General Motors

$35.13

0.01 (0.03%)

TSLA

Tesla

$190.80

-4.7 (-2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

  • 05

    Jun

  • 11

    Jun

  • 01

    Aug

RNLSY

Renault

$0.00

(0.00%)

13:14
05/25/19
05/25
13:14
05/25/19
13:14
Periodicals
Renault stock may rally, Barron's says »

Shares of French auto…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMC

FMC Corporation

$70.88

-0.47 (-0.66%)

, DWDP

DowDuPont

$31.10

0.16 (0.52%)

13:11
05/25/19
05/25
13:11
05/25/19
13:11
Periodicals
DowDuPont spinoff a new agriculture stock, FMC safer bet, Barron's says »

The crop-protection and…

FMC

FMC Corporation

$70.88

-0.47 (-0.66%)

DWDP

DowDuPont

$31.10

0.16 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 25

    Jun

MGM

MGM Resorts

$25.55

0.19 (0.75%)

13:03
05/25/19
05/25
13:03
05/25/19
13:03
Periodicals
MGM Resorts looks like an attractive gambling play, Barron's says »

MGM Resorts (MGM) stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

PYPL

PayPal

$109.82

-0.09 (-0.08%)

, AXP

American Express

$119.52

1.07 (0.90%)

12:30
05/25/19
05/25
12:30
05/25/19
12:30
Periodicals
Big tech failed to dethrone credit cards, Barron's says »

Rather than being cut out…

PYPL

PayPal

$109.82

-0.09 (-0.08%)

AXP

American Express

$119.52

1.07 (0.90%)

MA

MasterCard

$251.40

1.57 (0.63%)

V

Visa

$162.72

1.2 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 03

    Jun

  • 05

    Jun

  • 06

    Jun

  • 11

    Jun

  • 25

    Jun

  • 13

    Nov

GOOG

Alphabet

$1,132.99

-7.56 (-0.66%)

, GOOGL

Alphabet Class A

$1,138.90

-5.98 (-0.52%)

07:20
05/25/19
05/25
07:20
05/25/19
07:20
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

GOOG

Alphabet

$1,132.99

-7.56 (-0.66%)

GOOGL

Alphabet Class A

$1,138.90

-5.98 (-0.52%)

MSFT

Microsoft

$126.23

0.04 (0.03%)

AMBA

Ambarella

$38.28

1.07 (2.88%)

ON

ON Semiconductor

$17.68

-0.235 (-1.31%)

NKE

Nike

$82.12

-0.51 (-0.62%)

ADDYY

Adidas

$0.00

(0.00%)

UAA

Under Armour

$23.54

0.075 (0.32%)

UA

Under Armour

$20.91

0.08 (0.38%)

FL

Foot Locker

$44.39

-8.455 (-16.00%)

VMC

Vulcan Materials

$126.28

1.25 (1.00%)

FLR

Fluor

$29.04

0.18 (0.62%)

ACM

Aecom

$31.56

-0.03 (-0.09%)

X

U.S. Steel

$13.63

-0.08 (-0.58%)

AKS

AK Steel

$2.00

-0.155 (-7.21%)

NUE

Nucor

$51.12

-0.27 (-0.53%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$12.85

0.11 (0.86%)

F

Ford

$9.83

-0.02 (-0.20%)

GM

General Motors

$35.13

0.01 (0.03%)

HMC

Honda

$25.45

0.175 (0.69%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$118.54

1.16 (0.99%)

VWAGY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 03

    Jun

  • 03

    Jun

  • 04

    Jun

  • 04

    Jun

  • 05

    Jun

  • 06

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 12

    Jun

  • 13

    Jun

  • 19

    Jun

  • 19

    Jun

  • 23

    Jun

  • 09

    Jul

  • 24

    Jul

  • 31

    Jul

  • 01

    Aug

  • 06

    Aug

  • 23

    Oct

  • 27

    Oct

UBER

Uber

$41.40

0.94 (2.32%)

17:49
05/24/19
05/24
17:49
05/24/19
17:49
Hot Stocks
Uber board director Ryan Graves intends to resign »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

APTO

Aptose Biosciences

$2.01

0.03 (1.52%)

17:46
05/24/19
05/24
17:46
05/24/19
17:46
Syndicate
Aptose Biosciences files for $40M at-the-market common stock offering »

Piper Jaffray and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

TRNX

Taronis Technologies

$0.48

0.004 (0.84%)

17:26
05/24/19
05/24
17:26
05/24/19
17:26
Syndicate
Breaking Syndicate news story on Taronis Technologies »

Taronis Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:25
05/24/19
05/24
17:25
05/24/19
17:25
Hot Stocks
U.S. Energy discloses Nasdaq notice regarding delayed 10-Q filing »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

17:22
05/24/19
05/24
17:22
05/24/19
17:22
Periodicals
Apple sued over allegedly selling users' iTunes data, Bloomberg says »

Apple is being sued by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SPCB

SuperCom

$1.17

-0.005 (-0.43%)

17:21
05/24/19
05/24
17:21
05/24/19
17:21
Hot Stocks
SuperCom discloses Nasdaq notice regarding delayed 20-F filing »

SuperCom received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:20
05/24/19
05/24
17:20
05/24/19
17:20
Hot Stocks
U.S. Energy receives noncompliance notice from Nasdaq »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:18
05/24/19
05/24
17:18
05/24/19
17:18
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:17
05/24/19
05/24
17:17
05/24/19
17:17
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$87.49

3.03 (3.59%)

, QGEN

Qiagen

$38.22

-0.255 (-0.66%)

16:57
05/24/19
05/24
16:57
05/24/19
16:57
Hot Stocks
Qiagen launches diagnostic for PIK3CA biomarkers in breast cancer »

Qiagen (QGEN) announced…

NVS

Novartis

$87.49

3.03 (3.59%)

QGEN

Qiagen

$38.22

-0.255 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 31

    May

  • 20

    Jun

  • 06

    Aug

AVH

Avianca

$3.96

0.91 (29.84%)

16:56
05/24/19
05/24
16:56
05/24/19
16:56
Periodicals
ANAC suspends flights, operations of Avianca Brasil, Reuters reports »

Brazil's ANAC said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

16:53
05/24/19
05/24
16:53
05/24/19
16:53
Periodicals
Apple acquires startup Tueo Health, CNBC reports »

Apple has bought Tueo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SHSP

SharpSpring

$16.37

-0.24 (-1.44%)

16:52
05/24/19
05/24
16:52
05/24/19
16:52
Syndicate
Breaking Syndicate news story on SharpSpring »

SharpSpring files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

CREG

China Recycling Energy

$0.48

0.005 (1.05%)

16:41
05/24/19
05/24
16:41
05/24/19
16:41
Syndicate
Breaking Syndicate news story on China Recycling Energy »

China Recycling Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FENC

Fennec

$3.88

(0.00%)

16:36
05/24/19
05/24
16:36
05/24/19
16:36
Conference/Events
Fennec management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 18

    Jun

TD

Toronto-Dominion

$56.66

0.65 (1.16%)

16:35
05/24/19
05/24
16:35
05/24/19
16:35
Syndicate
Breaking Syndicate news story on Toronto-Dominion »

Toronto-Dominion files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
05/24/19
05/24
16:30
05/24/19
16:30
Options
Preliminary option volume of 15.7M today »

Preliminary option volume…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.